<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Merida Biosciences</title>
    <link>https://www.biospace.com/employer/3076372/merida-biosciences</link>
    <description>Merida Biosciences</description>
    <language>en-US</language>
    <lastBuildDate>Tue, 08 Apr 2025 20:24:09 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076372/merida-biosciences.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases</title>
      <link>https://www.biospace.com/press-releases/merida-biosciences-launches-with-121m-to-create-therapeutics-for-multiple-autoimmune-and-allergic-diseases</link>
      <description />
      <pubDate>Tue, 08 Apr 2025 20:24:09 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/merida-biosciences-launches-with-121m-to-create-therapeutics-for-multiple-autoimmune-and-allergic-diseases</guid>
    </item>
    <item>
      <title>Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases</title>
      <link>https://www.biospace.com/press-releases/lilly-to-acquire-merida-biosciences-to-advance-treatments-for-serious-autoimmune-and-allergic-diseases</link>
      <description />
      <pubDate>Mon, 31 Aug 2026 13:13:40 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/lilly-to-acquire-merida-biosciences-to-advance-treatments-for-serious-autoimmune-and-allergic-diseases</guid>
    </item>
  </channel>
</rss>
